Related Experiment Video
Updated: Aug 5, 2025

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
Applications of Genomics and Transcriptomics in Precision Medicine for Myopia Control or Prevention
Liqin Jiang1, Dong Xuan Goh2, James Hao Zhong Koh1
1Singapore Eye Research Institute, Singapore National Eye Centre, Eye ACP Duke-NUS Medical School, Singapore 169856, Singapore.
Abstract:
Myopia is a globally emerging concern accompanied by multiple medical and socio-economic burdens with no well-established causal treatment to control thus far. The study of the genomics and transcriptomics of myopia treatment is crucial to delineate disease pathways and provide valuable insights for the design of precise and effective therapeutics. A strong understanding of altered biochemical pathways and underlying pathogenesis leading to myopia may facilitate early diagnosis and treatment of myopia, ultimately leading to the development of more effective preventive and therapeutic measures. In this review, we summarize current data about the genomics and transcriptomics of myopia in human and animal models. We also discuss the potential applicability of these findings to precision medicine for myopia treatment.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Microorganisms in Medicine and Therapeutics
iPS Cell Differentiation

